Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
New York: Plenum Press
ANGPTL4 inhibits LPL activity by preventing the active homodimeric form of LPL from forming and by reducing the affinity of the monomers for binding to GPIHBP1 on the surface of capillary endothelial cells
Multiple imputation will be used for missing data
Improved insulin signaling helps the body process glucose more efficiently, reducing the tendency to store excess energy as fat
Additional studies have revealed that hyperphosphorylated tau protein can directly enhance the transcription of ACSL4, thereby intensifying the activity of the PUFAphosphatidylethanolamine (PUFAPE) pathway and accelerating lipid peroxidation
Clarifying these factors is essential for future trial design, the optimization of inclusion criteria, and the identification of the clinical phenotypes and healthcare settings most likely to benefit from GCSF therapy
